Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (4): 1000-1008.doi: 10.13481/j.1671-587X.20240414
• Research in basic medicine • Previous Articles Next Articles
Hua CHEN1,Na SHA1,Ning LIU1,Yang LI2,Haijun HU2()
Received:
2023-08-09
Online:
2024-07-28
Published:
2024-08-01
Contact:
Haijun HU
E-mail:huhaijun2386@163.com
CLC Number:
Hua CHEN,Na SHA,Ning LIU,Yang LI,Haijun HU. Effect of human bone marrow mesenchymal stem cells on biological behavior of human liposarcoma SW872 cells through YAP[J].Journal of Jilin University(Medicine Edition), 2024, 50(4): 1000-1008.
1 | HADDOX C L, RIEDEL R F. Recent advances in the understanding and management of liposarcoma[J]. Fac Rev, 2021, 10: 1. |
2 | JAFARI A, REZAEI-TAVIRANI M, FARHADIHOSSEINABADI B, et al. Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin[J]. Stem Cell Res Ther, 2021, 12(1): 126. |
3 | CUNNINGHAM R, HANSEN C G. The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer[J]. Clin Sci, 2022, 136(3): 197-222. |
4 | TRAUTMANN M, CHENG Y Y, JENSEN P,et al. Requirement for YAP1 signaling in myxoid liposarcoma[J]. EMBO Mol Med, 2019, 11(5): e9889. |
5 | ZANCONATO F, CORDENONSI M, PICCOLO S. YAP and TAZ: a signalling hub of the tumour microenvironment[J]. Nat Rev Cancer, 2019, 19(8): 454-464. |
6 | ANDRZEJEWSKA A, LUKOMSKA B, JANOWSKI M. Concise review: mesenchymal stem cells: from roots to boost[J]. Stem Cells, 2019, 37(7): 855-864. |
7 | TU B, ZHU J, LIU S, et al. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3[J]. Oncotarget, 2016, 7(30): 48296-48308. |
8 | ZENG J C, CHEN S S, LI C H, et al. Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression[J]. J Cancer, 2020, 11(8): 2068-2079. |
9 | GAO T, YU Y, CONG Q, et al. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor[J]. BMC Cancer, 2018, 18(1): 999. |
10 | NISHIKAWA G, KAWADA K, NAKAGAWA J, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5[J]. Cell Death Dis, 2019, 10(4): 264. |
11 | AL-TOUB M, ALMOHAWES M, VISHNUBALAJI R, et al. CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors[J]. Cell Death Discov, 2019, 5: 87. |
12 | CHEN J, JI T, WU D, et al. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma[J]. Cell Death Dis, 2019, 10(6): 425. |
13 | WENG Z J, ZHANG B W, WU C Z, et al. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer[J]. J Hematol Oncol, 2021, 14(1): 136. |
14 | LIN Z J, WU Y L, XU Y T, et al. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential[J]. Mol Cancer, 2022, 21(1): 179. |
15 | ZHANG X N, SAI B Q, WANG F, et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT[J]. Mol Cancer, 2019, 18(1): 40. |
16 | LI H D, LI F. Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p[J]. Br J Cancer, 2018, 119(6): 744-755. |
17 | MONTALTO F I, AMICIS F D. Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma[J]. Cells, 2020, 9(12): 2648. |
18 | MIZUNO T, MURAKAMI H, FUJII M, et al. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes[J]. Oncogene, 2012, 31(49): 5117-5122. |
19 | LOUIS-BRENNETOT C, COINDRE J M, FERREIRA C, et al. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors[J]. Genes Chromosomes Cancer, 2011, 50(11): 896-907. |
20 | YANG P P, CHEN W C, LI X H, et al. Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3[J]. Oncotarget, 2016, 7(22): 32652-32663. |
21 | HOSSEINI S, CHAMANI J, HADIPANAH M R, et al. Nano-curcumin’s suppression of breast cancer cells (MCF7) through the inhibition of cyclinD1 expression[J]. Breast Cancer, 2019, 11: 137-142. |
22 | GAO F, LI M, ZHOU L, et al. Xanthohumol targets the ERK1/2-Fra1 signaling axis to reduce cyclin D1 expression and inhibit non-small cell lung cancer[J]. Oncol Rep, 2020, 44(4): 1365-1374. |
23 | MENG H, LI J, SUN H P, et al. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway[J]. Drug Dev Res, 2023, 84(6): 1325-1334. |
24 | MONDAL S, ADHIKARI N, BANERJEE S, et al. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview[J]. Eur J Med Chem, 2020, 194: 112260. |
25 | WANG W M, LI D, XIANG L L, et al. TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9[J]. Cell Adh Migr, 2019, 13(1): 273-284. |
26 | KARMAKAR D, MAITY J, MONDAL P, et al. E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9[J]. Carcinogenesis, 2020, 41(12): 1767-1780. |
27 | LIU B Q, TIAN Y S, CHEN M Y, et al. CircUBAP2 promotes MMP9-mediated oncogenic effect via sponging miR-194-3p in hepatocellular carcinoma[J]. Front Cell Dev Biol, 2021, 9: 675043. |
28 | RODRIGUEZ R, TORNIN J, SUAREZ C, et al. Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation[J]. Stem Cells, 2013, 31(10): 2061-2072. |
29 | KIM Y J, KIM M, PARK H K, et al. Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology[J]. Lab Invest, 2019, 99(9): 1309-1320. |
30 | JO E B, LEE H, LEE K W, et al. Complete regression of metastatic de-differentiated liposarcoma with engineered mesenchymal stromal cells with dTRAIL and HSV-TK[J]. Am J Transl Res, 2020, 12(7): 3993-4000. |
[1] | Yongjing YANG,Tianyang KE,Shixin LIU,Xue WANG,Dequan XU,Tingting LIU,Ling ZHAO. Synergistic sensitization of apatinib mesylate and radiotherapy on hepatocarcinoma cells invitro [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1009-1015. |
[2] | Chaojie GUO,Jiajia ZHANG,Jie ZENG,Huiyu WANG, AIERFATI·Aimaier,Jiang XU. Expressions of PLOD1 in oral squamous cell carcinoma tissue and cells and their significances [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1035-1043. |
[3] | Yilin REN,Yichen ZANG,Lele XUE,Kaige YANG,Sufang CHEN,Weinan WANG,Chenghua LUO,Weihua LIANG,Lianghai WANG,Feng LI,Jianming HU. Bioinformatics analysis based on effect of M2 macrophage-derived Siglec15 on malignant biological behaviour of esophageal squamous cell carcinoma cells and its experimental validation [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 881-890. |
[4] | Guoxing YU,Xin ZHANG,Hengwei DU,Bingjie CUI,Na GAO,Cuilan LIU,Jing DU. Effect of urolithin C on proliferation, apoptosis and autophagy of human acute myeloid leukemia HL-60 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 908-916. |
[5] | Shan CAO,Yijia ZHANG,Yang BAI,Fang CHEN,Sha XIE,Qianqian HAN. Network pharmacological analysis and in vitro experimental verification based on anti-atherosclerosis mechanism of Xiaoban Tongmai Formula [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 925-938. |
[6] | Yuan WANG,Zhijuan WANG,Mingshu ZHANG,Yihui WANG,Qing ZHANG,Liping YE. Effects of monocyte chemoattractant protein-1 on invasion and migration of lung cancer A549 and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 666-675. |
[7] | Bo YUAN,Jiayi XIE,Siyu JIANG,Yajun MENG,Qinghua ZHU,Xiaofei LI,Xiumei FU,Lide XIE. Effect of adipose-derived stem cell-derived exosomes on migration ability of macrophages in vitro [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 718-727. |
[8] | Shuang CHEN,Hong LI. Effect of silencing FOXK1 gene on proliferation, migration, and invasion of gastric cancer HGC-27 cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 371-378. |
[9] | Huijuan SONG,Zhenhua XU,Dongning HE. Effect of apolipoprotein C1 expression on proliferation and apoptosis of human liver cancer HepG2 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 128-135. |
[10] | Yanhong WEI,Chenxue YANG,Guangmin YANG,Shuai SONG,Ming LI,Haijiao YANG,Haifeng WEI. Inhibitory effect of downregulating HMGB2 expression on epithelial-mesenchymal transition of liver cancer LM3 cells and its AKT/mTOR signaling pathway mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 143-149. |
[11] | Jie ZENG,Xueyan YU,Ting LUO,Jiang XU. Effect of PD-L1 on proliferation, migration, and invasion of human oral squamous carcinoma cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 18-24. |
[12] | Jia ZHOU,Zhidong QIU,Zhe LIN,Guangfu LYU,Jiaming XU,He LIN,Kexin WANG,Yuchen WANG,Xiaowei HUANG. Effect of chelerythrine on migration, invasion, and epithelial-mesenchymal transition of human ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 25-32. |
[13] | Yuxue SUN,Ziqiang LIU,Hao WU,Liming ZHAO,Tao GAO,Haiyan HUANG,Chaoyue LI. Inhibitory effect of berberine on migration and invasion of human glioma T98G cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 50-57. |
[14] | Xiaoni WANG,Tao GUO,Qiyun LUO,Lifeng GUAN. Effect of usnic acid on biological behaviors of hypertrophic scar fibroblasts and JNK/MAPK signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1445-1451. |
[15] | Aihua REN,Xinda JU,Aofei LIU,Yongchao LIU,Yanfeng LIU. Effect of ganoderic acid A on proliferation and apoptosis of human non-small cell lung cancer PC-9 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1466-1472. |
|